Market Cap 3.84B
Revenue (ttm) 2.70B
Net Income (ttm) -128.04M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -4.74%
Debt to Equity Ratio 1.99
Volume 2,578,321
Avg Vol 2,524,474
Day's Range N/A - N/A
Shares Out 200.09M
Stochastic %K 18%
Beta 1.16
Analysts Strong Sell
Price Target $21.21

Company Profile

Alignment Healthcare, Inc. operates a consumer-centric healthcare platform for seniors in the United States. It delivers customized healthcare experience to meet the needs of seniors through its Medicare Advantage plans. The company was founded in 2013 and is based in Orange, California.

Industry: Healthcare Plans
Sector: Healthcare
Phone: 844 310 2247
Address:
1100 West Town and Country Road, Suite 1600, Orange, United States
BillionerOfKing
BillionerOfKing Dec. 10 at 7:13 PM
$ALHC Current Stock Price: $19.11 Contracts to trade: $20 ALHC Dec 19 2025 Call Entry: $0.15 Exit: $0.21 ROI: 43% Hold ~24 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 10 at 4:46 AM
Actionable Trade Alert for $ALHC: Market Context: $ALHC closed at $19.21, with a strong RSI of 83.88 indicating overbought conditions. The stock is currently above its 30-day moving average (MA30) of 17.6 and 50-day moving average (MA50) of 17.45, suggesting bullish momentum. The 60-day high of 19.99 provides a resistance level, while the low of 15.85 indicates a solid support base. Directional Bias: Despite the high RSI, the stock remains in an uptrend, supported by its MAs. However, caution is warranted due to the overbought RSI. Trade Plan: - Suggested Entry: $19.21 - Stop Loss: $18.50 (approx. 3.7% risk) - Take Profit Targets: 1. $19.75 (2.8% gain) 2. $20.50 (6.7% gain) 3. $22.50 (17.5% gain) This plan offers a potential ROI of over 17% on the third target while maintaining a reasonable risk-reward ratio. Monitor closely for any signs of reversal. https://privateprofiteers.com
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 9 at 12:34 AM
Actionable Trade Alert for $ALHC: Market Context: $ALHC is currently trading at $19.35, showing strong bullish momentum with an RSI of 86.7, indicating overbought conditions. The stock is above its 30-day MA of $17.55 and 50-day MA of $17.41, reinforcing a bullish trend. The recent 60-day high of $19.99 suggests potential resistance ahead. Directional Bias: Given the high RSI, we anticipate a pullback may occur, but the overall trend remains bullish. The stock is positioned well above its recent low of $15.85, indicating strong buying interest. Trade Plan: - Suggested Entry: $19.35 - Stop Loss: $18.50 (4.4% risk) - Take Profit Targets: 1. $20.00 (3.4% gain) 2. $21.00 (8.5% gain) 3. $22.65 (17.4% gain) This plan allows for a potential ROI of over 17% on the third target, while maintaining a reasonable risk-reward ratio. Monitor closely for any signs of reversal due to the high RSI. https://privateprofiteers.com
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 6 at 3:33 AM
Actionable Trade Alert for $ALHC: Market Context: $ALHC closed at $19.4, showing strong momentum with an RSI of 76.89, indicating overbought conditions. The stock is currently above both the 30-day MA (17.42) and 50-day MA (17.33), suggesting bullish sentiment. However, the high of $19.99 within the last 60 days indicates potential resistance. Directional Bias: Given the high RSI and proximity to the 60D high, caution is warranted. A pullback could occur, but if momentum continues, we can capitalize on potential upside. Trade Plan: - Suggested Entry: $19.4 - Stop Loss: $18.5 (5% below entry) - Take Profit Targets: 1. $20.0 (3.1% gain) 2. $21.5 (10.7% gain) 3. $22.8 (17.5% gain) Rationale: Target 3 provides a 17.5% ROI, aligning with our goal. Monitor RSI for signs of reversal and adjust stop loss accordingly. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 5 at 11:09 PM
Actionable Trade Alert for $ALHC: Market Context: $ALHC closed at $19.4, showing strong momentum with an RSI of 76.89, indicating overbought conditions. The stock is currently above both the 30-day MA (17.42) and 50-day MA (17.33), suggesting bullish sentiment. However, the high of $19.99 within the last 60 days indicates potential resistance. Directional Bias: Given the high RSI and proximity to the 60D high, caution is warranted. A pullback could occur, but if momentum continues, we can capitalize on potential upside. Trade Plan: - Suggested Entry: $19.4 - Stop Loss: $18.5 (5% below entry) - Take Profit Targets: 1. $20.0 (3.1% gain) 2. $21.5 (10.7% gain) 3. $22.8 (17.5% gain) Rationale: Target 3 provides a 17.5% ROI, aligning with our goal. Monitor RSI for signs of reversal and adjust stop loss accordingly. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
Theironsheikh
Theironsheikh Nov. 25 at 10:15 PM
$CLOV $ALHC up 65% YTD $OSCR up 24% YTD This piece of shit down 23% YTD And people think Toy is a good ceo Motherfucker
4 · Reply
JarvisFlow
JarvisFlow Nov. 24 at 2:56 PM
JP Morgan has updated their rating for Alignment Healthcare ( $ALHC ) to Overweight with a price target of 20.
0 · Reply
tartanblaster
tartanblaster Nov. 21 at 9:50 AM
$CLOV before everyone panics Worth highlighting how good value current metrics puts us P/S - 0.61, 34% lower than our closest comparator $ALHC Value is even more stark when you consider enterprise value (the better metric especially since we have zero debt and reasonable cash reserves) EV/S - 0.45, 45% lower than Alignment Basically 80% upside just to equalise valuation metrics with our peers
1 · Reply
Rorx
Rorx Nov. 15 at 4:39 AM
$ALHC 18 to 21 before it crashes down to around 13 if not lower
0 · Reply
JarvisFlow
JarvisFlow Nov. 5 at 7:29 PM
JP Morgan has adjusted their stance on Alignment Healthcare ( $ALHC ), setting the rating to Neutral with a target price of 17 → 18.
0 · Reply
Latest News on ALHC
Analyst Favors Cigna, Alignment Healthcare, Cautious On Peers

Sep 2, 2025, 2:00 PM EDT - 3 months ago

Analyst Favors Cigna, Alignment Healthcare, Cautious On Peers

CI


Alignment Healthcare, Inc. (ALHC) Q4 2024 Earnings Call Transcript

Feb 28, 2025, 5:32 PM EST - 10 months ago

Alignment Healthcare, Inc. (ALHC) Q4 2024 Earnings Call Transcript


Alignment Healthcare Reports Third Quarter 2024 Results

Oct 29, 2024, 4:01 PM EDT - 1 year ago

Alignment Healthcare Reports Third Quarter 2024 Results


Alignment Healthcare Updates its Board of Directors

Aug 16, 2024, 4:30 PM EDT - 1 year ago

Alignment Healthcare Updates its Board of Directors


Alignment Healthcare Reports Second Quarter 2024 Results

Aug 1, 2024, 4:01 PM EDT - 1 year ago

Alignment Healthcare Reports Second Quarter 2024 Results


BillionerOfKing
BillionerOfKing Dec. 10 at 7:13 PM
$ALHC Current Stock Price: $19.11 Contracts to trade: $20 ALHC Dec 19 2025 Call Entry: $0.15 Exit: $0.21 ROI: 43% Hold ~24 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 10 at 4:46 AM
Actionable Trade Alert for $ALHC: Market Context: $ALHC closed at $19.21, with a strong RSI of 83.88 indicating overbought conditions. The stock is currently above its 30-day moving average (MA30) of 17.6 and 50-day moving average (MA50) of 17.45, suggesting bullish momentum. The 60-day high of 19.99 provides a resistance level, while the low of 15.85 indicates a solid support base. Directional Bias: Despite the high RSI, the stock remains in an uptrend, supported by its MAs. However, caution is warranted due to the overbought RSI. Trade Plan: - Suggested Entry: $19.21 - Stop Loss: $18.50 (approx. 3.7% risk) - Take Profit Targets: 1. $19.75 (2.8% gain) 2. $20.50 (6.7% gain) 3. $22.50 (17.5% gain) This plan offers a potential ROI of over 17% on the third target while maintaining a reasonable risk-reward ratio. Monitor closely for any signs of reversal. https://privateprofiteers.com
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 9 at 12:34 AM
Actionable Trade Alert for $ALHC: Market Context: $ALHC is currently trading at $19.35, showing strong bullish momentum with an RSI of 86.7, indicating overbought conditions. The stock is above its 30-day MA of $17.55 and 50-day MA of $17.41, reinforcing a bullish trend. The recent 60-day high of $19.99 suggests potential resistance ahead. Directional Bias: Given the high RSI, we anticipate a pullback may occur, but the overall trend remains bullish. The stock is positioned well above its recent low of $15.85, indicating strong buying interest. Trade Plan: - Suggested Entry: $19.35 - Stop Loss: $18.50 (4.4% risk) - Take Profit Targets: 1. $20.00 (3.4% gain) 2. $21.00 (8.5% gain) 3. $22.65 (17.4% gain) This plan allows for a potential ROI of over 17% on the third target, while maintaining a reasonable risk-reward ratio. Monitor closely for any signs of reversal due to the high RSI. https://privateprofiteers.com
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 6 at 3:33 AM
Actionable Trade Alert for $ALHC: Market Context: $ALHC closed at $19.4, showing strong momentum with an RSI of 76.89, indicating overbought conditions. The stock is currently above both the 30-day MA (17.42) and 50-day MA (17.33), suggesting bullish sentiment. However, the high of $19.99 within the last 60 days indicates potential resistance. Directional Bias: Given the high RSI and proximity to the 60D high, caution is warranted. A pullback could occur, but if momentum continues, we can capitalize on potential upside. Trade Plan: - Suggested Entry: $19.4 - Stop Loss: $18.5 (5% below entry) - Take Profit Targets: 1. $20.0 (3.1% gain) 2. $21.5 (10.7% gain) 3. $22.8 (17.5% gain) Rationale: Target 3 provides a 17.5% ROI, aligning with our goal. Monitor RSI for signs of reversal and adjust stop loss accordingly. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
PrivateProfiteersAnalyst
PrivateProfiteersAnalyst Dec. 5 at 11:09 PM
Actionable Trade Alert for $ALHC: Market Context: $ALHC closed at $19.4, showing strong momentum with an RSI of 76.89, indicating overbought conditions. The stock is currently above both the 30-day MA (17.42) and 50-day MA (17.33), suggesting bullish sentiment. However, the high of $19.99 within the last 60 days indicates potential resistance. Directional Bias: Given the high RSI and proximity to the 60D high, caution is warranted. A pullback could occur, but if momentum continues, we can capitalize on potential upside. Trade Plan: - Suggested Entry: $19.4 - Stop Loss: $18.5 (5% below entry) - Take Profit Targets: 1. $20.0 (3.1% gain) 2. $21.5 (10.7% gain) 3. $22.8 (17.5% gain) Rationale: Target 3 provides a 17.5% ROI, aligning with our goal. Monitor RSI for signs of reversal and adjust stop loss accordingly. For more insights, visit https://privateprofiteers.com. https://privateprofiteers.com
0 · Reply
Theironsheikh
Theironsheikh Nov. 25 at 10:15 PM
$CLOV $ALHC up 65% YTD $OSCR up 24% YTD This piece of shit down 23% YTD And people think Toy is a good ceo Motherfucker
4 · Reply
JarvisFlow
JarvisFlow Nov. 24 at 2:56 PM
JP Morgan has updated their rating for Alignment Healthcare ( $ALHC ) to Overweight with a price target of 20.
0 · Reply
tartanblaster
tartanblaster Nov. 21 at 9:50 AM
$CLOV before everyone panics Worth highlighting how good value current metrics puts us P/S - 0.61, 34% lower than our closest comparator $ALHC Value is even more stark when you consider enterprise value (the better metric especially since we have zero debt and reasonable cash reserves) EV/S - 0.45, 45% lower than Alignment Basically 80% upside just to equalise valuation metrics with our peers
1 · Reply
Rorx
Rorx Nov. 15 at 4:39 AM
$ALHC 18 to 21 before it crashes down to around 13 if not lower
0 · Reply
JarvisFlow
JarvisFlow Nov. 5 at 7:29 PM
JP Morgan has adjusted their stance on Alignment Healthcare ( $ALHC ), setting the rating to Neutral with a target price of 17 → 18.
0 · Reply
IN0V8
IN0V8 Nov. 3 at 2:48 PM
$ALHC Barclays raises target price to $18 from $13
0 · Reply
JarvisFlow
JarvisFlow Nov. 3 at 2:20 PM
Barclays has updated their rating for Alignment Healthcare ( $ALHC ) to Equal-Weight with a price target of 18.
0 · Reply
IN0V8
IN0V8 Oct. 31 at 6:53 PM
$ALHC Buy Leerink Partners raises PT to $23 from $20 Stephens raises target price to $24 from $20 UBS raises target price to $18 from $17
0 · Reply
tartanblaster
tartanblaster Oct. 31 at 1:34 PM
$CLOV $ALHC Doing well after very strong earnings yesterday Should give us some confidence that medical cost inflation has levelled us and hopefully see us reporting similarly storing earnings
2 · Reply
AStrokeOfLuck
AStrokeOfLuck Oct. 30 at 9:31 PM
0 · Reply
Cash_Only_Account
Cash_Only_Account Oct. 30 at 8:40 PM
$CLOV $ALHC Alignment Healthcare banging it. https://finance.yahoo.com/quote/ALHC/
0 · Reply
tartanblaster
tartanblaster Oct. 30 at 11:47 AM
$CLOV $ALHC earnings are the ones to watch today after hours. The closest comparator to Clover, what trends they've seen in medical costs will give us best idea of what to expect on Nov 4th
0 · Reply
Helpmrwizard
Helpmrwizard Oct. 28 at 9:12 PM
$ALHC this looks like it could explode to the upside in a few weeks; call option premiums are hefty all the way to $30 per share, chart looks great
0 · Reply
Gorohanada
Gorohanada Oct. 21 at 3:13 PM
$ALHC has best ratings for adult care
0 · Reply
JarvisFlow
JarvisFlow Oct. 14 at 12:36 PM
Goldman Sachs updates rating for Alignment Healthcare ( $ALHC ) to Buy, target set at 21.
0 · Reply
TrendEdgeLogan
TrendEdgeLogan Oct. 8 at 7:01 PM
$ALHC $3.34B mc founder-led 👑 $XLV Hidden Gem 💎 (just 283 watchers on @stocktwits !) rotating up above a fresh gold-cross and rising 80-week SMA. Picture perfect base and volume profile - Pct of all funds at Record highs & rising 🏦 - AI Council is BULLISH with a BUY recommendation 🐂✅ TrendEdge.app/asset/ALHC cc @WAJeff @MaverikIT
0 · Reply
tartanblaster
tartanblaster Oct. 3 at 12:49 PM
$CLOV as painful as this week has been, it won't last When we recover it will be rapid, the valuation fundamentals don't lie. Currently sitting at a P/S of 0.79, and EV/REV (my preferred as reflects our lack of debt) of 0.6. Vs closest comparator of $ALHC of 0.95 & 0.9 Mad that $CLOV growing at 35%+ per annum has worth valuation metrics than $UNH ! (0.87 EV/REV)
0 · Reply